ESCEO-AMGEN Fellowship Award 2011

The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is pleased to announce two Osteoporosis Fellowship Awards, courtesy of a grant of Amgen.

The intent of these awards is to provide support to eligible institutions to develop and enhance the opportunities for physicians or PhD’s training for careers in Osteoporosis.

Recipients will be selected primarily on the basis of the quality of the research proposal outlined in the application. Only one application per fellow may be submitted.

The Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) will review the applications.

This fifth ESCEO-Amgen Fellowship Awards will be presented during the “Fellowship Awards Ceremony” at ECCEO11-IOF. The recipients will each receive $50,000 US for 1 year to support their fellowship stipend. (Institutions may be asked to certify that funds will be applied towards stipend only. These funds are non-renewable).

All awards applications and supporting materials must be submitted on or before February 15, 2011 through this website and by mail. Late or incomplete packages will not be considered. Applications will be notified of the committee’s decision no later than March 5, 2011.

More info and form by clicking this link (submission closed)

ESCEO-IOF/Servier Achievement Award – Pierre Delmas Prize

The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) will present in 2011 the second edition of the Pierre Delmas Prize, with the support of Servier.

Pierre Delmas, Professor of Medecine and Rheumatology at the University of Lyon, France, Director of the INSERM research unit “Pathophysiology of Osteoporosis”, was an outstanding scientist who directed essential basic and clinical research in metabolic bone diseases, particulary in osteoporosis and osteoarthritis

He was the Founding President of the IOF

Servier, an independant research-orientated pharmaceutical company with a long history of relationships with researchers and clinicians, particulary in the field of osteoporosis and osteoarthritis, is proud to participate, as sole sponsor, in the creation of the Pierre Delmas Prize.

The Pierre Delmas Prize will be awarded every year to an individual for outstanding and major scientific contributions to the study of bone and mineral diseases, and consists of a grant of €40,000 and a medal.

The prize Committee will be composed of remarkable Scientists chosen within the IOF Committee of Scientific Advisors and ESCEO Scientific Advisory Board. The second edition of the Pierre Delmas Prize will be granted in March 2011 in Valencia during the ECCO11-IOF Congress

More info and form by clicking this link (submission closed)

ESCEO Young Investigators Awards (supported by a grant from MSD)

The ESCEO Young Investigator Awards, supported by a grant from MSD, recognize young investigators for their excellence in bone and mineral research. The award includes a €2,500 honorarium and is given to the lead investigator of the 2 (two) highest scored abstracts submitted for presentation at the ECCEO11-IOF Annual Meeting.

More info

Herbert A. Fleisch ESCEO-IOF Medal

ESCEO and IOF have established an important new award, valued at 20,000 euros, which recognizes a researcher who has made outstanding and groundbreaking achievements in basic bone science. The award is named in honour of Herbert Fleisch, a renowned researcher whose groundbreaking work considerably influenced knowledge about bone and mineral metabolism.

Gerard Karsenty

The inaugural Herbert A. Fleisch Medal has been awarded to Professor Gerard Karsenty of the Columbia University Medical Center, in recognition of his many fundamental contributions to the understanding of skeletal development and skeletal physiology. The Medal will be presented on March 23rd at an award ceremony to take place at the opening of the European Congress on Osteoporosis & Osteoarthritis. Click here to see press release of March 9, 2011